Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with sickle cell disease (any type)
- You are already a participant in the Sickle Cell Clinical Research and Intervention Program
- You are between 12 and 25 years old at the time of joining the trial
- English is your main language
- You have access to a device (such as a phone, tablet, or computer) with WiFi
Who may not be able to join:
- You have a history of an intellectual disability
- You have had a traumatic brain injury or have a seizure disorder (such as epilepsy)
- You have had a stroke
- You are currently receiving a treatment intended to cure sickle cell disease, such as a stem cell transplant or gene therapy
- You are currently taking prescribed medication or receiving treatment for a sleep disorder
- You or your legal guardian are unable or unwilling to sign a written consent form to take part in research
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrew Heitzer, Phd, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the relationship between nocturnal oxyhemoglobin saturation (SpO2) and neurocognitive functioning (working memory and verbal comprehension) in individuals (ages 12-25) diagnosed with sickle cell disease.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.